SUBSCRIBE
SUBSCRIBE
News   FDA

Boston Scientific Corporation Gets Conditional OK for Liberte Stent

March 19, 2008 | 
1 min read
CHICAGO (Reuters) - Medical device maker Boston Scientific Corp (BSX.N: Quote, Profile, Research) said on Tuesday its newest drug-eluting stent, the Taxus Liberte system, has received conditional approval from U.S. regulators.
FDA Approvals
MORE ON THIS TOPIC
Pictured: Boehringer Ingelheim sign on a building/
Approvals
Boehringer Ingelheim Breaks Decade-Long Approval Drought in Idiopathic Pulmonary Fibrosis
October 8, 2025
 · 
2 min read
 · 
Tristan Manalac
Regulatory
Marks Finds His Next Role as Lilly Snags Another Former FDA Regulator
October 7, 2025
 · 
1 min read
 · 
Heather McKenzie
Traffic light silhouette and golden sky.
ALS
FDA Lifts Clinical Hold, Clearing Neurizon’s ALS Drug for Human Trials
October 6, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Manufacturing
FDA Continues US Manufacturing Drive With Domestic Generics Pilot
October 6, 2025
 · 
2 min read
 · 
Tristan Manalac